Alloreactivity
Showing 1 - 25 of 77
Intestinal Transplantation Trial in New York (Cell Therapy)
Recruiting
- Intestinal Transplantation
- Cell Therapy
-
New York, New YorkColumbia University Irving Medical Center/NYP
Dec 28, 2021
ALLoreactive T-Cell receptOr RePertoire in kidnEy
Recruiting
- Renal Transplant Rejection
- +3 more
- Mixed lymphocyte reaction
-
Vienna, AustriaMedical university of Vienna
Apr 5, 2022
Stem Cell Transplant Complications Trial (MHC typing, KIR typing, Assessment of KIR-based prediction scores)
Completed
- Stem Cell Transplant Complications
- MHC typing
- +2 more
- (no location specified)
May 9, 2021
First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney
Active, not recruiting
- Kidney Diseases
- +5 more
- Booster dose of mRNA vaccine
-
Praha, CzechiaInstitute for Clinical and Experimental Medicine
Aug 2, 2022
Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)
Completed
- Acute Leukemia
- +4 more
-
Atlanta, GeorgiaNorthside Hospital
Sep 1, 2021
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)
Recruiting
- AML - Acute Myeloid Leukemia
- +5 more
- T-allo10
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Metabolic and Infectious Complications Post Belatacept
Not yet recruiting
- Kidney Transplant Infection
- +3 more
- Oral glucose tolerance test
- (no location specified)
Mar 29, 2022
Amputation, Traumatic, Amputation;Traumatic;Old, Face Injury Trial in Boston (IL-2)
Terminated
- Amputation, Traumatic
- +4 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 22, 2021
Acute Myeloid Leukemia Trial in Xi'an (infusion of natural killer cells)
Recruiting
- Acute Myeloid Leukemia
- infusion of natural killer cells
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Apr 17, 2022
Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived
Not yet recruiting
- Recurrent Gliosarcoma
- +2 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- Resection
-
Houston, TexasM D Anderson Cancer Center
May 24, 2022
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Cerebral Ischemia Trial in Seattle (Endovascular autologous mitochondrial transplantation)
Recruiting
- Cerebral Ischemia
- Endovascular autologous mitochondrial transplantation
-
Seattle, WashingtonHarborview Medical Center
Aug 1, 2021
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Palo Alto (Ibrutinib, Laboratory
Unknown status
- Acute Biphenotypic Leukemia
- +4 more
- Ibrutinib
- Laboratory Biomarker Analysis
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jan 28, 2021
High-risk Leukemias Trial in Spain (NK cells stimulated ex vivo with IL-15, Alloreactive NK cells)
Recruiting
- High-risk Leukemias
- NK cells stimulated ex vivo with IL-15
- Alloreactive NK cells
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Mar 30, 2022
Ocular Surface Disease in Chronic Graft-Versus-Host Disease
Recruiting
- Dry Eye
- GVHD
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Hematologic Diseases Trial in Italy
Completed
- Hematologic Diseases
-
Alessandria, Italy
- +38 more
Aug 19, 2021
Corona Virus Infection Trial in Madrid (T memory cells and NK cells)
Recruiting
- Corona Virus Infection
- T memory cells and NK cells
-
Madrid, SpainHospital Universitario La Paz
Oct 14, 2020
Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))
Completed
- Healthy
- AMD 3100 (Mozobil plerixafor)
- Granulocyte colony-stimulating factor (G-CSF)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021
End Stage Liver Disease Trial in Chicago (Leukapheresis)
Terminated
- End Stage Liver Disease
- Leukapheresis
-
Chicago, IllinoisNorthwestern University Comprehensive Transplant Center
Aug 22, 2019
Osteosarcoma, Neuroblastoma Trial in Houston (genetic, biological, drug)
Active, not recruiting
- Osteosarcoma
- Neuroblastoma
- GD2 T cells
- +3 more
-
Houston, Texas
- +1 more
Apr 16, 2021
Leukemia Trial in Badalona, Hospitalet de Llobregat, Barcelona (DLI of the 20 fraction of the UCBT)
Completed
- Leukemia
- DLI of the 20 fraction of the UCBT
-
Badalona, Barcelona, Spain
- +4 more
Dec 3, 2021
GVHD, Malignancy Trial in Canada, United States (Abatacept, )
Active, not recruiting
- Graft vs Host Disease
- Malignancy
- Abatacept
- placebo
-
Los Angeles, California
- +13 more
Jan 9, 2023
Safety Issues Trial in Cali (Neonatal thymus transplantation)
Recruiting
- Safety Issues
- Neonatal thymus transplantation
-
Cali, Valle Del Cauca, ColombiaFundación Valle Del Lili
Dec 14, 2022
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021